Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster session 17

128P - Biliary tract cancers: Epidemiological and prognosis trends of Latin American population

Date

21 Oct 2023

Session

Poster session 17

Topics

Cancer Epidemiology

Tumour Site

Hepatobiliary Cancers

Presenters

Maria del Consuelo Diaz Romero

Citation

Annals of Oncology (2023) 34 (suppl_2): S215-S232. 10.1016/S0923-7534(23)01929-4

Authors

M.D.C. Diaz Romero1, G. Calderillo Ruiz1, E. García1, B. CARBAJAL2, D.A.G. Padilla3, G.E. Trejo-Duran4, P. Morales Esponda Mendoza5, D.L. Guerra Figueroa6

Author affiliations

  • 1 Medical Oncology Department, INCAN - Instituto Nacional de Cancerologia, 14080 - Ciudad de Mexico/MX
  • 2 Clinical Research, INCAN - Instituto Nacional de Cancerologia, 14080 - Ciudad de Mexico/MX
  • 3 Dept. Cirugía Oncológica, INCAN - Instituto Nacional de Cancerologia, 14080 - Ciudad de Mexico/MX
  • 4 Radiation Oncology, The National Cancer Institute, 14080 - Ciudad de Mexico/MX
  • 5 Facutlad De Medicina, UNAM - Universidad Nacional Autonoma de Mexico, 04510 - Ciudad de Mexico/MX
  • 6 Facultad De Medicina, UNAM - Universidad Nacional Autonoma de Mexico, 04510 - Ciudad de Mexico/MX

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 128P

Background

Biliary tract cancers are heterogeneous tumors defined by the anatomical location, intrahepatic, cholangiocarcinoma (ICC), extrahepatic (ECC), gallbladder and ampulla of Vater cancer (AVC).The outcome of treatment by location remains unclear in Latin American population, resulting in inconsistently data to enhance treatment decisions and outcome. The aim of this study is to describe the epidemiological features and prognosis of overall survival of Latin American population with biliary tract cancers.

Methods

Retrospective, observational study. Included patients treated at the National Cancer Institute between 2008 and 2022. Statistical analysis required: X2 and t test, Kaplan Meier, Log Rank and Cox Regression. Statistical significance differences were assessed when p was bilaterally <0.05.

Results

A total 786 of patients diagnosed with biliary tract cancer were included in the analysis. Patients had a median age of 61 years (24-96). Alcohol consumption and smoking were observed in 22% and 29% respectively. Regarding comorbidities, 22% had Type2DM, 27% HAS, and obesity & overweight was present in 13% and 32% respectively. Anatomical location included ICC (19%;n=151), ECC (22%;n=172), gallbladder (33%;n=259) and AVC (26%;n=204). Female were more prevalent in gallbladder and ICC (79% & 71%) (p<0.001). Median time to diagnosis was 3 months (0–120); extent of disease was observed as localized (18%;n=144), local-advanced (20%;n=158), and metastatic (60%;n=472). In metastatic patients, mean number of metastasis was 1 (1-7), being liver (66%), retroperitoneum (7%), and lung (6%) the most frequent sites. Comparing Chemotherapy and extent of disesase, 35%, 53%, and 55% patients received treatment for localized, unresectable, and metastatic (p=0.001). An OS analysis was conducted considering location, ICC patients showed a median-OS of 9months, ECC a median-OS of 12months, gallbladder a median-OS of 1months and AVC did not reach median-OS (p<0.001).

Conclusions

Prognosis and outcome for patients with biliary tract cancer differ depending on the anatomical subsite. This is one of the main studies describing epidemiological features, and outcome in Latin American patients with biliary tract.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The authors.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.